EPISODE · Jun 9, 2021
Parasites: The Good, the Bad, the Ugly with Dr Mark Donohoe
from FX Medicine Podcast Central
Are all parasites bad for us? Not necessarily. Dr Mark Donohoe returns to FX Medicine to discuss all things parasites, from treatments using helminths, to why clinical trials using parasites might be flawed, why we should think twice before trying to “wipe out” a parasitic infection, and how some parasites have evolved alongside humans to be a benefit, rather than a detriment to our health. Find today's transcript and show notes here: https://www.fxmedicine.com.au/podcast/parasites-good-bad-ugly-dr-mark-donohoe *****DISCLAIMER: The information provided on FX Medicine is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.*****
What this episode covers
Are all parasites bad for us? Not necessarily. Dr Mark Donohoe returns to FX Medicine to discuss all things parasites, from treatments using helminths, to why clinical trials using parasites might be flawed, why we should think twice before trying to “wipe out” a parasitic infection, and how some parasites have evolved alongside humans to be a benefit, rather than a detriment to our health. Find today's transcript and show notes here: https://www.fxmedicine.com.au/podcast/parasites-good-bad-ugly-dr-mark-donohoe *****DISCLAIMER: The information provided on FX Medicine is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.*****
NOW PLAYING
Parasites: The Good, the Bad, the Ugly with Dr Mark Donohoe
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m